Abstract:OBJECTIVE:To study the associations between paraoxonase, 55 Met/Leu (PON1 55 Met/ Leu), paraoxonase2 148 Ala/Gly (PON2 148 Ala/Gly) and manganese superoxide dismutase 9 Ala/Val (MnSOD 9 Ala/Val) genetic polymorphisms and coronary heart disease (CHD), plasma activities of paraoxonase (PON), total superoxide dismutase (T-SOD), MnSOD, as well as plasma concentration of maleic dialdehyde (MDA).METHODS:Using PCR-RFLP method to identify genotype of PON1 55 Met/Leu, PON2 148 Ala/Gly and MnSOD 9 Ala/Val genetic polymorphisms, and using colorimetry to detect plasma activities of PON, T-SOD, MnSOD and plasma concentration of MDA in 262 CHD patients and 100 controls.RESULTS:Compared with controls, the plasma activities of PON [(349.27 +/- 138.36 vs. 454.75 +/- 166.00) nmol x min(-1) x ml(-1), P < 0.001], T-SOD [(23.61 +/- 16.51 vs. 44.01 +/- 22.68) U/ml, P < 0.001] and MnSOD [(21.56 +/- 13.11 vs. 28.79 +/- 8.65) U/ml, P < 0.001] reduced obviously,while plasma MDA concentration increased markedly [(2.47 +/- 0.73 vs. 2.15 +/- 0.55)nmol/ml, P < 0.01] in CHD patients. There were more LM genotype and Met allele of PON, 55 Met/Leu (24.8% vs. 1.4%, P < 0.001 and 12.4% vs. 0.5%, P = 0.001, respectively), GG and AG genotype and G allele of PON2 148 Ala/Gly (11.8% vs. 5.0%, P < 0.001, 48.1% vs. 24.0%, P < 0.001 and 36.0% vs. 17.0%, P < 0.001, respectively) and AA genotype, A allele of MnSOD 9 Ala/Val genetic polymorphisms (64.2% vs. 43.0%, P = 0.001 and 80.0% vs. 67.0%, P = 0.014, respectively) in CHD patients than in controls. The activities of plasma PON and T-SOD were lower in individuals with PON1 55 LM genotype than those with LL genotype. The activity of plasma PON was also lower in individuals with PON2 148 GG/AG genotype than those with AA genotype. The activities of plasma PON and MnSOD depressed in individuals with MnSOD AA genotype compared with those with VV genotype. Logistic regression analysis demonstrated that PON1 55 LM genotype, PON2 148 GG/AG genotype and G allele were independent risk factors for CHD.CONCLUSION:The antioxidative ability decreased, while lipid superoxide increased in CHD patients. Gene polymorphisms of PON1 55 Met/Leu, PON2 148 Ala/Gly and MnSOD 9 Ala/Val seemed to involve in the morbidity of CHD by influencing the plasma activities of PON and MnSOD.

Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life.

Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.

In Schizophrenia, PON1 Q192R Genotypes and/or Lowered Paraoxonase 1 (PON1) Enzymatic Activity are Significantly Associated with the Deficit Syndrome, Negative Symptoms, Formal Thought Disorders, Psychomotor Retardation, Excitation and Increased IgA Levels to Gram-Negative Microbiota

Lowered Paraoxonase 1 (PON1) Activity is Associated with Increased Cytokine Levels in Drug Naïve First Episode Psychosis

Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

Increased Nitro-Oxidative Stress Toxicity As a Major Determinant of Increased Blood Pressure in Mood Disorders

Deficit Schizophrenia and Its Features Are Associated with PON1 Q192R Genotypes and Lowered Paraoxonase 1 (PON1) Enzymatic Activity: Effects on Bacterial Translocation.

Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder

Association of Paraoxonase (PON)1 Activity, Glutathione S-transferase GST T1/M1 and STin.2 Polymorphisms with Comorbidity of Tobacco Use Disorder and Mood Disorders

Paraoxonase 1 Status is a Major Janus-faced Component of Mild and Moderate Acute Ischemic Stroke and Consequent Disabilities

Lowered Quality of Life in Mood Disorders is Associated with Increased Neuro-Oxidative Stress and Basal Thyroid-Stimulating Hormone Levels and Use of Anticonvulsant Mood Stabilizers

Paraoxonase (pon)1 Q192r Functional Genotypes and Pon1 Q192r Genotype by Smoking Interactions Are Risk Factors for the Metabolic Syndrome, but Not Overweight or Obesity

Association Between PON1 Activity and Coronary Heart Disease Risk: a Meta-Analysis Based on 43 Studies.

Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.

Increased Nitro-Oxidative Toxicity in Association with Metabolic Syndrome, Atherogenicity and Insulin Resistance in Patients with Affective Disorders

Shared Metabolic and Immune-Inflammatory, Oxidative and Nitrosative Stress Pathways in the Metabolic Syndrome and Mood Disorders

Plasma Paraoxonase-1, Oxidized Low-Density Lipoprotein and Lipid Peroxidation Levels in Gout Patients

Study of the Association Between Paraoxonase1 55 Met/Leu, Paraoxonase2 148 Ala/Gly and Manganese Superoxide Dismutase (mnsod) 9 Ala/Val Genetic Polymorphisms and Coronary Heart Disease

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation

Association of Serum Paraoxonase/Arylesterase Activity with All-Cause Mortality in Maintenance Hemodialysis Patients.